RPG Life Sciences Limited — Updates, 27-01-2026: General Updates
27-01-2026 | 08:35 pm
27-01-2026 | 08:35 pm
RPG Life Sciences' quarterly revenue rose 4.2% to 180.0 Cr, but PAT fell 19.8% to 27.9 Cr. Nine-month PAT was 82.6 Cr. API sales declined due to a fire. The debt-free company pursues 'mega-brand' growth and global expansion, supported by 140 Cr capex.
No comments yet. Be the first to comment!
